Clinical Trials Directory

Trials / Conditions / Sickle Cell Disorders

Sickle Cell Disorders

9 registered clinical trials studyying Sickle Cell Disorders — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingStudy to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sick
NCT05904093
National Heart, Lung, and Blood Institute (NHLBI)Phase 1
RecruitingA Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
NCT04201210
University of RegensburgPhase 2
UnknownGenoMed4ALL: Improving SCD Classification and Prognosis by AI
NCT06019208
Hospital Universitari Vall d'Hebron Research Institute—
CompletedTo Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With
NCT04134299
Axcella Health, IncN/A
TerminatedSafety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects
NCT02433158
GlycoMimetics IncorporatedPhase 3
WithdrawnPhase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
NCT01925001
SangartPhase 2
TerminatedEffects of HQK-1001 in Patients With Sickle Cell Disease
NCT01601340
HemaQuest Pharmaceuticals Inc.Phase 2
CompletedSafety Study of MP4CO in Adult Sickle Cell Patients
NCT01356485
SangartPhase 1
CompletedA Study of HQK-1001 in Patients With Sickle Cell Disease
NCT01322269
HemaQuest Pharmaceuticals Inc.Phase 2